Louise Kiru

Louise Kiru has a diverse work experience in the field of biomedical research. Louise started their career as a Doctoral Student at UCL, where they worked on genetically modifying T-cells for noninvasive imaging and establishing tumor models in mice. Louise then joined Stanford University School of Medicine as a Postdoctoral Research Fellow, where they focused on molecular imaging and metabolic reprogramming of the tumor microenvironment. During their time at Stanford, they also served as an Instructor for a course on medical imaging. Most recently, Louise joined Adicet Bio, Inc as a Sr. Scientist CAR T-cell and Immunobiology, where their specific responsibilities are not provided.

Louise Kiru has a comprehensive education history. In 2007, they attended the University of Leicester and completed a Bachelor of Science degree in Medical Biochemistry, which they finished in 2010. Following their undergraduate studies, Louise pursued further education and attended Imperial College London from 2011 to 2012. During this time, they obtained a Master of Research degree in Biomedical Research. Continuing their academic journey, they enrolled at UCL in 2012 and completed their Doctor of Philosophy (PhD) in Medical Physics and Bioengineering in 2015. In 2018, Louise attended the Stanford University Graduate School of Business specifically for the Stanford Ignite program, where they obtained a Certificate in Innovation and Entrepreneurship. Additionally, Louise has also been associated with the Stanford University School of Medicine, although specific details regarding the degree or field of study are not provided.